Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004523 · ClinicalTrials.gov registry record
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 135
- Enrollment target
NCT01004523: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT01004523 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 135 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01004523 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from patients with low-grade glioma.
Interventions
- GENETIC polymerase chain reaction
- OTHER immunohistochemistry staining method
- OTHER flow cytometry
- GENETIC fluorescence in situ hybridization
- GENETIC loss of heterozygosity analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 1995-12 |
| Est. Completion | 2013-03 |
What the finished NCT01004523 record still lists
NCT01004523 is an observational study that tracks outcomes without assigning an intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which polymerase chain reaction is the first listed.
NCT01004523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01004523 about?
NCT01004523 is a clinical study titled "Study of Tissue and Blood Samples From Patients With Low-Grade Glioma". RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research st...
What is the current status of trial NCT01004523?
This trial is currently completed. The enrollment target is 135 participants. The study started on 1995-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01004523?
The interventions under investigation include: polymerase chain reaction (GENETIC), immunohistochemistry staining method (OTHER), flow cytometry (OTHER), fluorescence in situ hybridization (GENETIC), loss of heterozygosity analysis (GENETIC).
Who is sponsoring clinical trial NCT01004523?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia